BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

ADAMIS PHARMACEUTICALS CORPORATION — Receipts Report

LD-2 disclosure · 1st Quarter - Termination

ADAMIS PHARMACEUTICALS CORPORATION

via CASSIDY & ASSOCIATES, INC.

1st Quarter (Jan 1 - Mar 31) · 2012Posted Jul 11, 2012Filing document ↗LDA record ↗

Income$10Kfee reported

Client

Name: ADAMIS PHARMACEUTICALS CORPORATION
Description: Pharmaceutical
Location: California · United States of America

Registrant

Firm: CASSIDY & ASSOCIATES, INC.
Description: Government relations
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Pharmacy
regualtory relief with FDA
LobbyistsSHAWN EDWARDS · TERRY PAUL
Covered position (SHAWN EDWARDS): Senate Armed Service Committee
Covered position (TERRY PAUL): Brig Gen (Marines); Marine Corps Liaison (Sen)
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.